Transcriptional Fingerprinting meets Drug Discovery
Transcriptional Fingerprinting meets Drug Discovery
Transcriptional Fingerprinting meets Drug Discovery
Mission
QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.
Read more about the Company & Our Science.
News
30.04.2021
Dr. Maier joins QUANTRO Therapeutics as Independent Board Chairman
30.04.2021
Now hiring:
Head of Pharmacology
19.02.2021
Now hiring:
Research Technician Molecular Biology
16.04.2021
QUANTRO Therapeutics delighted to join BIOTECH AUSTRIA as a member.
QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria
© 2021 QUANTRO Therapeutics GmbH